 |
|
|
 | Watson Pharmaceuticals Inc (NYSE:WPI) | 9/3/2010 |  |
| WEDNESDAY, SEPTEMBER 01, 2010 | | 8:00 AM | Watson to Present at the Morgan Stanley Global Healthcare Unplugged Conference - PR Newswire |  | | TUESDAY, AUGUST 31, 2010 | | 8:00 AM | ScinoPharm to Invest in Tanvex Biologics - PR Newswire |  | | FRIDAY, AUGUST 13, 2010 | | 5:07 PM | Watson Plans Q4 2010 ella(R) (ulipristal acetate) Emergency Contraceptive Launch - PR Newswire |  | | MONDAY, AUGUST 09, 2010 | | 10:56 AM | Fitch Upgrades Watson Pharmaceuticals' IDR to 'BBB'; Outlook Stable - BusinessWire |  | | THURSDAY, AUGUST 05, 2010 | | 7:00 AM | Watson Q2 Net Revenue Climbs 29 Percent to $875 Million - PR Newswire |  | | 5:40 AM | Watson Pharmaceuticals hires Sigurdur Oli Olafsson as executive vice president of global generics - M2 |  | | WEDNESDAY, AUGUST 04, 2010 | | 8:45 AM | Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics - PR Newswire |  | | 5:06 AM | Watson Pharmaceuticals names Robert Stewart as executive vice president, global operations - M2 |  | | TUESDAY, AUGUST 03, 2010 | | 4:15 PM | Watson Promotes Robert Stewart to Executive Vice President, Global Operations - PR Newswire |  | | THURSDAY, JULY 15, 2010 | | 7:55 AM | Watson and Itero Enter Worldwide License Agreement on Biologic Development Candidate - PR Newswire |  |
|
|
 |